ANN ARBOR, MI (US), January 2020 — How do a couple of universally expressed proteins in stem cells and developing embryos influence an individual cell's ultimate fate — whether it ultimately becomes, for example, a retinal cell, a heart muscle cell or a stomach lining cell?
You are here
Coverage of the latest news and updates from the field of stem cells and regenerative medicine.
AURORA, CO (US), January 2020 — A massive research effort over more than a quarter century has tried to make personalized blood stem cells for use in treating leukemias, among many other uses.
BERLIN (DE), January 2020 — The Gouti lab from the Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC) has developed functional neuromuscular organoids (NMOs) that self-organize into spinal cord neurons and muscle tissue.
TELTOW (DE), January 2020 — For decades, researchers have been learning how to steer stem cells’ differentiation process by changing their environment. The knowledge acquired is already being used in tissue engineering.
Cambridge, MA (US), January 2020 — More than 20 years ago, the lab of developmental biologist Olivier Pourquié, Ph.D., discovered a sort of cellular clock in chicken embryos where each “t
BOSTON, MA (US), January 2020 — Researchers have developed a new way to generate groups of intestinal cells that can be used, among others, to make disease models in the lab to test treatments for diseases affecting the gastrointestinal system.
BOULDER, CO (US), January 2020 — The red, tube-shaped flowers of the firecracker bush (Bouvardia ternifolia), native to Mexico and the American Southwest, attract hummingbirds.
MELBOURNE (AU), January 2020 — Researchers have reproduced and visualized the earliest developmental steps in human immune cell production in the laboratory and are now set to advance our understanding of childhood diseases like leukemia and autoimmune conditions.
BOSTON, MA (US), January 2020 — A new analysis shows that a donor stem cell transplant following treatment with an immune checkpoint inhibitor is generally safe and produces good outcomes for patients with Hodgkin lymphoma, easing concerns that these patients are at heightened ri